home / stock / tkno / tkno news


TKNO News and Press, Alpha Teknova Inc.

Stock Information

Company Name: Alpha Teknova Inc.
Stock Symbol: TKNO
Market: NASDAQ

Menu

TKNO TKNO Quote TKNO Short TKNO News TKNO Articles TKNO Message Board
Get TKNO Alerts

News, Short Squeeze, Breakout and More Instantly...

TKNO - Conestoga Capital Advisors Q1 2024 Commentary

2024-05-26 12:20:00 ET Summary Conestoga Capital Advisors LLC is a boutique, independent investment advisory firm specializing in the management of Micro, Small, SMid and Mid Cap Growth equities. Conestoga Capital Advisors utilizes a fundamental, bottom-up research process and employs...

TKNO - Alpha Teknova, Inc. (TKNO) Q1 2024 Earnings Call Transcript

2024-05-17 10:55:05 ET Alpha Teknova, Inc. (TKNO) Q1 2024 Earnings Conference Call May 13, 2024, 5:00 PM ET Company Participants Jennifer Henry - Senior Vice President of Marketing Stephen Gunstream - President and Chief Executive Officer Matthew Lowell - Chief F...

TKNO - Alpha Teknova GAAP EPS of -$0.20 beats by $0.05, revenue of $9.3M beats by $0.68M

2024-05-13 17:06:48 ET More on Alpha Teknova Alpha Teknova, Inc. (TKNO) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Alpha Teknova Historical earnings data for Alpha Teknova Financial information for Alpha Teknova Read the...

TKNO - Teknova Reports First Quarter 2024 Financial Results

First quarter 2024 total revenue was $9.3 million, up 2% from prior year Launch of Build-Tek™ Custom Configurator Company reaffirms 2024 revenue guidance of $35-38 million HOLLISTER, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”...

TKNO - Expected US Company Earnings on Monday, May 13th, 2024

Aileron Therapeutics Inc. (ALRN) is expected to report for Q1 2024 DZS Inc. (DZSI) is expected to report $-0.09 for Q1 2024 Bitfarms Ltd. (BITF) is expected to report $-0.03 for Q1 2024 180 Degree Capital Corp. (TURN) is expected to report for quarter end 2024-03-31 Abacus Life In...

TKNO - Teknova Launches Proprietary Build-Tek(TM) Solutions Custom Configurator and Latest AAV-Tek(TM) Product to Further Accelerate Novel Therapy Development

First-of-its-kind custom configurator – available today – gives scientists access to high quality, customizable buffers in small volumes for use in early-stage experiments, all with exceptionally short turnaround times Novel, multi-purpose AAV stabilizer solution increases cap...

TKNO - Teknova to Report First Quarter 2024 Financial Results on May 13, 2024

HOLLISTER, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Compa...

TKNO - Alpha Teknova, Inc. (TKNO) Q4 2023 Earnings Call Transcript

2024-03-12 06:33:06 ET Alpha Teknova, Inc. (TKNO) Q4 2023 Earnings Conference Call March 11, 2024, 05:30 PM ET Company Participants Jennifer Henry - Senior Vice President of Marketing Stephen Gunstream - President & Chief Executive Officer Matthew Lowell - Ch...

TKNO - Alpha Teknova GAAP EPS of -$0.26 misses by $0.02, revenue of $7.9M misses by $0.42M

2024-03-11 16:03:41 ET More on Alpha Teknova Read the full article on Seeking Alpha For further details see: Alpha Teknova GAAP EPS of -$0.26 misses by $0.02, revenue of $7.9M misses by $0.42M

TKNO - Teknova Reports Fourth Quarter and Full Year 2023 Financial Results

Full year 2023 total revenue was $36.7 million, down 11% year-over-year Achieved 36% annual growth in the number of Clinical Solutions customers in 2023 Company provides 2024 revenue guidance of $35-38 million HOLLISTER, Calif., March 11, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, ...

Next 10